Member Info for cmww2014

Thoughts on why BRII has tanked this morning ?

80p haha Woodstock you're trolling us

An earlier trial of molnupiravir in hospitalised patients was stopped after disappointing results.

Seems to me a wholly different product.

If it costs £700 per treatment but you need to give it to 10x more people it doesn't seem like great value for money to me !

HSD - seems like in-vitro testing with Delta might be in the pipeline too and could re-focus the need/ potential benefit of SNG.

That's an excellent question Katie [that was written by the synairgen comms director and given to you this morning]
Rich nice and relaxed all smiles, Katie tried to make him say he expected rollout early 22 but Mr Marsden was true to his IFs

Mid November until last patient dosed
~85 in October
~45 to pick up in November

over 100 sites active and less than 130 trialists to find

Shouldn't be advertising on a public forum that you're breaking the law storing fuel Woodstock ;)

By 1630 she'll be belting out Nessun Dorma like an angel.

They were an impressive lot over at Activ so fingers crossed we hear soon; and they bring their cheque book !

Hi Josh, did you get this from the lessons learnt presentation.
I wasn't sure whether trial progression of specific treatments would be discussed in the meeting today, to me it sounded more like a leadership meeting; high level strategy and the like ?

Is mumbo-jumbo Eva ?
Whenever I see Bank of Valetta on the recent comments haha

On the Q&A Tuesday it was mentioned that there will be a leadership meeting today.
What could they be discussing ?
Did anybody else clock this ?

Mostly focusing on device selection for nebulised COPD/ covid treatments.
Published on the 28th if not seen already.
Nothing too interesting (that I gleamed) other that the fact the paper exists (!)
https://www.dovepress.com/treating-copd-patients-with-inhaled-medications-in-the-era-of-covid-19-peer-reviewed-fulltext-article-COPD

If your closest Johnny I'll buy the pork scratchings !

173p

Trying to temper my expectations for tomorrow so I'll be happy with an EUA announcement, 1million treatments manufactured/ ready to shipped and a knighthood for Marsden.

I submitted a question relating to assurances of manufacture before selecting tialists, I'm not sure it was asked explicitly but the topic was talked about at length. I'm pretty content that SNG must have shown they are very capable of stepping up manufacture else they wouldn't be here.

Do we suspect that the trialist requiring a BSL3 lab was us ?

Thanks for the replies, a very encouraging session overall.

Some lovely soundbites around not just covid that this will benefit !

Not shown on the stakeholders slide ... hmmm